
### [MONDO:0019298](http://purl.obolibrary.org/obo/MONDO_0019298)
**Label:** rare urticaria

**Subclasses:** [MONDO:0019315](http://purl.obolibrary.org/obo/MONDO_0019315) (diffuse cutaneous mastocytosis), [MONDO:0019316](http://purl.obolibrary.org/obo/MONDO_0019316) (Maculopapular cutaneous mastocytosis), [MONDO:0019023](http://purl.obolibrary.org/obo/MONDO_0019023) (cutaneous mastocytosis), 

**Corr. equiv. classes:** [Orphanet:79457](http://www.orpha.net/ORDO/Orphanet_79457), [OMIM:154800](http://purl.obolibrary.org/obo/OMIM_154800), [Orphanet:66646](http://www.orpha.net/ORDO/Orphanet_66646), [Orphanet:79456](http://www.orpha.net/ORDO/Orphanet_79456), 

**Class expressions from DL-Learner:**

- [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 100.00%
- [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 100.00%
- [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 100.00%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 100.00%
- [HP:0008069](http://purl.obolibrary.org/obo/HP_0008069) (Neoplasm of the skin) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 100.00%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 100.00%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 100.00%
- [HP:0001000](http://purl.obolibrary.org/obo/HP_0001000) (Abnormality of skin pigmentation) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 100.00%
- [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 87.50%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 87.50%
- [HP:0012733](http://purl.obolibrary.org/obo/HP_0012733) (Macule) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 87.50%
- [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 87.50%
- [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 87.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 87.50%
- [HP:0001009](http://purl.obolibrary.org/obo/HP_0001009) (Telangiectasia) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 87.50%


